Query
Search
Aggregations
Jurisdiction
United States
8
World
8
Canada
4
Date
New (last 4 weeks)
1
2025 January (MTD)
1
2024 December
1
2025 (YTD)
1
2024
2
2023
2
2022
4
2021
1
2020
8
Before 2020
2
See more
See less
IPC Class
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
14
C12N 15/13 - Immunoglobulins
11
C12P 21/08 - Monoclonal antibodies
9
A61P 31/04 - Antibacterial agents
8
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
7
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
6
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
6
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
5
A61P 31/12 - Antivirals
5
A23K 20/195 - Antibiotics
4
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
4
A61K 39/00 - Medicinal preparations containing antigens or antibodies
4
A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
4
C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
4
A23L 33/18 - Peptides; Protein hydrolysates
3
A61K 9/00 - Medicinal preparations characterised by special physical form
3
C07K 14/015 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
3
C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
3
C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
3
C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
3
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
2
A61P 33/00 - Antiparasitic agents
2
A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
2
C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
2
C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
2
C12P 21/00 - Preparation of peptides or proteins
2
C40B 40/08 - Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
2
A01G 7/06 - Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
1
A01N 63/50 - Isolated enzymes; Isolated proteins
1
A01P 1/00 - Disinfectants; Antimicrobial compounds or mixtures thereof
1
See more
See less
Status
Pending
10
Registered / In Force
10
Found results for
patents
1.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Application Number
18777457
Status
Pending
Filing Date
2024-07-18
First Publication Date
2025-01-09
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip
Cheung, Tsz Ying Silvia
Abstract
Described are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 31/04 - Antibacterial agents
2.
ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF
Application Number
18599359
Status
Pending
Filing Date
2024-03-08
First Publication Date
2024-12-05
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A23K 20/195 - Antibiotics
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/18 - Peptides; Protein hydrolysates
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61P 31/04 - Antibacterial agents
3.
ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
Application Number
CA2023051462
Publication Number
2024/092360
Status
In Force
Filing Date
2023-11-02
Publication Date
2024-05-10
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.
IPC Classes ?
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61K 31/12 - Ketones
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies
4.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF PLANTS AND USES THEREOF
Application Number
CA2023050279
Publication Number
2023/205876
Status
In Force
Filing Date
2023-03-03
Publication Date
2023-11-02
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Cheung, Tsz Ying Sylvia
Tupin, Audrey
Abstract
The present technology generally relates to methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in a plant.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A01N 63/50 - Isolated enzymes; Isolated proteins
A01P 1/00 - Disinfectants; Antimicrobial compounds or mixtures thereof
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C12N 15/13 - Immunoglobulins
C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
C12P 21/08 - Monoclonal antibodies
5.
ANTIBODIES AGAINST DISEASE-CAUSING AGENTS APPLIED TO PLANT VASCULAR SYSTEMS
Application Number
US2023063611
Publication Number
2023/168357
Status
In Force
Filing Date
2023-03-02
Publication Date
2023-09-07
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
INVAIO SCIENCES, INC. (USA)
Inventor
Abnousi, Hamlet
Loutet, Slade
Cheung, Tsz Ying Sylvia
Slovic, Avram Michael
Sheahan, Anjali Viswa
Ursin, Virginia Marie
Malvar Jr., Thomas Michael
Abstract
Provided herein are methods and systems useful for providing an antibody to a vascular plant, including effecting binding of an exogenous antibody to its corresponding antigen in a vascular plant. The methods and systems include introducing at least one exogenous antibody, such as at least one exogenous nanobody, into a plant's vascular system (e.g., into xylem or phloem or both).
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A01G 7/06 - Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A61P 31/04 - Antibacterial agents
6.
Antibodies against microorganisms and uses thereof
Application Number
17409559
Grant Number
11939371
Status
In Force
Filing Date
2021-08-23
First Publication Date
2022-08-18
Grant Date
2024-03-26
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Abstract
HH fragments for reducing a bacterial population in domestic animals or humans.
IPC Classes ?
A61K 39/02 - Bacterial antigens
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A23K 20/195 - Antibiotics
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A23L 33/18 - Peptides; Protein hydrolysates
A61K 9/00 - Medicinal preparations characterised by special physical form
A61P 31/04 - Antibacterial agents
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/00 - Medicinal preparations containing antigens or antibodies
7.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Application Number
17528783
Status
Pending
Filing Date
2021-11-17
First Publication Date
2022-08-04
Owner
Novobind Livestock Therapeutics, Inc. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a parasite population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a parasite population in an animal.
IPC Classes ?
C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
8.
ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
Application Number
15734939
Status
Pending
Filing Date
2019-06-04
First Publication Date
2022-04-21
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
9.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF
Application Number
17292160
Status
Pending
Filing Date
2019-11-12
First Publication Date
2022-03-03
Owner
Novobind Livestock Therapeutics, Inc. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.
10.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Application Number
17141052
Status
Pending
Filing Date
2021-01-04
First Publication Date
2021-09-02
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip
Cheung, Tsz Ying Silvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
11.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Document Number
03140739
Status
Pending
Filing Date
2020-05-19
Open to Public Date
2020-11-26
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a parasite population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a parasite population in an animal.
IPC Classes ?
C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 33/00 - Antiparasitic agents
A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies
12.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Application Number
IB2020000380
Publication Number
2020/234642
Status
In Force
Filing Date
2020-05-19
Publication Date
2020-11-26
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade
Van Petegem, Filip
Cheung, Tsz, Ying Sylvia
Abstract
HHH fragments for reducing a parasite population in an animal.
IPC Classes ?
C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 33/00 - Antiparasitic agents
A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies
13.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF
Document Number
03118819
Status
Pending
Filing Date
2019-11-12
Open to Public Date
2020-05-22
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.
IPC Classes ?
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61P 31/12 - Antivirals
C07K 14/015 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies
14.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF
Application Number
IB2019001196
Publication Number
2020/099922
Status
In Force
Filing Date
2019-11-12
Publication Date
2020-05-22
Owner
NOVOBIND LIVESTOCK THERAPEUTICS, INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade, Andrew
Van Petegem, Filip
Cheung, Tsz, Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.
IPC Classes ?
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61P 31/12 - Antivirals
C07K 14/015 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies
15.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Document Number
03103656
Status
Pending
Filing Date
2019-07-03
Open to Public Date
2020-02-20
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip Louis Arsene
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
A61P 31/04 - Antibacterial agents
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
C12N 15/13 - Immunoglobulins
C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
C12P 21/08 - Monoclonal antibodies
16.
ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
Application Number
IB2019001198
Publication Number
2020/035741
Status
In Force
Filing Date
2019-07-03
Publication Date
2020-02-20
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade, Andrew
Van Petegem, Filip Louis Arsene
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
A61P 31/04 - Antibacterial agents
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
C12N 15/13 - Immunoglobulins
C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
C12P 21/08 - Monoclonal antibodies
17.
ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
Document Number
03102039
Status
Pending
Filing Date
2019-06-04
Open to Public Date
2020-01-09
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade Andrew
Van Petegem, Filip Louis Arsene
Cheung, Tsz Ying Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61P 31/12 - Antivirals
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
C12N 15/13 - Immunoglobulins
C12P 21/00 - Preparation of peptides or proteins
C40B 40/08 - Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
18.
ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
Application Number
IB2019000687
Publication Number
2020/008254
Status
In Force
Filing Date
2019-06-04
Publication Date
2020-01-09
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Loutet, Slade, Andrew
Van Petegem, Filip Louis, Arsene
Cheung, Tsz Ying, Sylvia
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
A61P 31/12 - Antivirals
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
C12N 15/13 - Immunoglobulins
C12P 21/00 - Preparation of peptides or proteins
C40B 40/08 - Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
19.
Antibodies against microorganisms and uses thereof
Application Number
16300457
Grant Number
11130800
Status
In Force
Filing Date
2017-05-19
First Publication Date
2019-07-04
Grant Date
2021-09-28
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.
IPC Classes ?
A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A23K 20/195 - Antibiotics
A23L 33/18 - Peptides; Protein hydrolysates
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
A61P 31/04 - Antibacterial agents
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 39/00 - Medicinal preparations containing antigens or antibodies
20.
ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF
Application Number
IB2017000684
Publication Number
2017/199094
Status
In Force
Filing Date
2017-05-19
Publication Date
2017-11-23
Owner
NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
Abnousi, Hamlet
Abstract
Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.
IPC Classes ?
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
A23K 20/195 - Antibiotics
A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
A61P 31/04 - Antibacterial agents
C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
C12N 15/13 - Immunoglobulins
C12P 21/08 - Monoclonal antibodies